VINCENT CASCIO MD
Prescription History 1457857039
Internal Medicine - Endocrinology, Diabetes & Metabolism in Manhasset, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for VINCENT CASCIO MD, an active Endocrinology, Diabetes & Metabolism specialist practicing in Manhasset, NY. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 185 documented patient claims. Among these therapy options, the most frequently utilized medication is Metformin Hcl, which accounts for 34 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Metformin Hcl | 34 | $5.43▼ below NY avg | ▼ Less than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 34 Medicare prescriptions for Metformin Hcl, about a third of the volume of the typical New York prescriber of this medication (98). Medicare paid an average of $5.43 per fill, versus $10.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 80 30-Day Fills standardized to 30-day supplies 2,400 Days of Medication total across all patients in 2024 | |||
| Levothyroxine Sodium | 28 | $14.17 | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 28 Medicare prescriptions for Levothyroxine Sodium, about a quarter of the volume of the typical New York prescriber of this medication (133.5). Medicare paid an average of $14.17 per fill, versus $13.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 62 30-Day Fills standardized to 30-day supplies 1,860 Days of Medication total across all patients in 2024 | |||
| OzempicSemaglutide | 27 | $1,455.89 | ▼ Less than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 27 Medicare prescriptions for Ozempic, about half the volume of the typical New York prescriber of this medication (63.3). Medicare paid an average of $1,455.89 per fill, versus $1,284.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43.7 30-Day Fills standardized to 30-day supplies 1,284 Days of Medication total across all patients in 2024 | |||
| Atorvastatin Calcium | 25 | $15.59 | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2024, this provider wrote 25 Medicare prescriptions for Atorvastatin Calcium, about 13% of the volume of the typical New York prescriber of this medication (194.9). Medicare paid an average of $15.59 per fill, versus $10.41 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63 30-Day Fills standardized to 30-day supplies 1,890 Days of Medication total across all patients in 2024 | |||
| TrulicityDulaglutide | 16 | $1,633.34 | ▼ Less than typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. A glucagon-like peptide-1 receptor agonist; GLP-1 immunoglobulin G (IgG4) Fc fusion protein with extended activity. In 2024, this provider wrote 16 Medicare prescriptions for Trulicity, about a third of the volume of the typical New York prescriber of this medication (42.2). Medicare paid an average of $1,633.34 per fill, versus $1,286.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26.8 30-Day Fills standardized to 30-day supplies 784 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 15 | $15.89 | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 15 Medicare prescriptions for Alendronate Sodium, about a third of the volume of the typical New York prescriber of this medication (51.9). Medicare paid an average of $15.89 per fill, versus $7.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40.2 30-Day Fills standardized to 30-day supplies 1,204 Days of Medication total across all patients in 2024 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 15 | $54.35▼ below NY avg | ▼ Less than typical |
In 2024, this provider wrote 15 Medicare prescriptions for Nano 2nd Gen Pen Needle, about half the volume of the typical New York prescriber of this medication (34.7). Medicare paid an average of $54.35 per fill, versus $94.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 28 30-Day Fills standardized to 30-day supplies 800 Days of Medication total across all patients in 2024 | |||
| Novolog FlexpenInsulin Aspart | 13 | $259.93 | ▼ Less than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2024, this provider wrote 13 Medicare prescriptions for Novolog Flexpen, about a third of the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $259.93 per fill, versus $205.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.3 30-Day Fills standardized to 30-day supplies 1,089 Days of Medication total across all patients in 2024 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $293.29▼ below NY avg | ▼ Less than typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. In 2024, this provider wrote 12 Medicare prescriptions for Basaglar Kwikpen U-100, about a third of the volume of the typical New York prescriber of this medication (35.6). Medicare paid an average of $293.29 per fill, versus $324.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 31.3 30-Day Fills standardized to 30-day supplies 940 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for VINCENT CASCIO MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Endocrinology, Diabetes & Metabolism prescribing approach at this Manhasset, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
